接种疫苗的中国儿童乙型肝炎核心抗体流行率:一项基于医院的调查
该研究分析了215,627名接种过乙肝疫苗的住院中国儿童的抗-HBc阳性率,发现0岁组为36.6%(可能为母源),1-10岁组稳定在约5.69%,11-16岁组升至7.80%;HBsAg在9岁以上儿童中显著升高至1.40%,提示免疫后突破感染可能。
要点
- 0岁组抗-HBc阳性率36.6%,可能为母体来源。
- 1-16岁儿童抗-HBc平均5.99%,HBsAg平均0.63%。
- 9岁以上儿童HBsAg阳性率1.40%,需关注突破感染。
核心结论
- 接种乙肝疫苗的中国儿童中,0岁组抗-HBc阳性率36.6%可能为母源,1-16岁组抗-HBc阳性率相对较高(平均5.99%),9岁以上儿童HBsAg阳性率升高提示可能发生突破感染。
研究设计与样本
- 基于医院的横断面研究,分析了215,627名接种过乙肝疫苗的住院中国儿童的抗-HBc和HBsAg阳性率。
主要发现
- 抗-HBc阳性率分三个阶段:0岁组36.6%;1-10岁组相对稳定(5.69±0.40%,[4.86-6.28%]);11-16岁组显著上升(7.80±1.24%,[6.62-9.74%])。
- HBsAg在9岁以上儿童中显著升高至1.40%([1.00-2.04%]),而0岁组为0.30%,1-9岁组为0.55±0.13%(0.30-0.64%)。
- 1-16岁儿童抗-HBc平均阳性率为5.99%,HBsAg平均阳性率为0.63%。
关键数值与推荐
- 抗-HBc阳性率:0岁组36.6%;1-10岁组5.69±0.40%([4.86-6.28%]);11-16岁组7.80±1.24%([6.62-9.74%])。
- HBsAg阳性率:0岁组0.30%;1-9岁组0.55±0.13%(0.30-0.64%);9岁以上儿童1.40%([1.00-2.04%])。
- 1-16岁儿童抗-HBc平均5.99%,HBsAg平均0.63%。
临床怎么用
- 对9岁以上已接种乙肝疫苗的儿童应关注HBsAg筛查,警惕突破感染可能。
- 0岁婴儿抗-HBc阳性需考虑母体被动转移,应结合HBsAg和HBV DNA判断。
局限性
- 研究基于住院儿童,可能存在选择偏倚,结果外推至一般儿童人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: After nearly 30 years of immunization, there is little known about the prevalence of hepatitis B core antibody (anti-HBc) in Chinese children. The clinical significance of anti-HBc would be more and more important. In this study, we had tried to analyse the prevalence of anti-HBc in vaccinated Chinese children, exploring the post-immunization status based on a large sample sized investigation. METHODS: Proportions of anti-HBc were analysed among 215,627 hospitalized Chinese children immunized with HBV vaccination in this study. RESULTS: The proportions of anti-HBc were divided into 3 stages: 36.6% in 0-year-old group, followed by 1- to 10-year-old which stayed relatively stable (5.69 ± 0.40%, [4.86-6.28%]), and significant increasing within 11- to 16-year-old (7.80 ± 1.24%, [6.62-9.74%]), meanwhile, similar changes of HBsAg were showed in the corresponding ages, and significantly increased in children older than 9-year (1.40%, [1.00-2.04%]), comparing with 0.30% in 0-year-old, 0.55 ± 0.13% (0.30-0.64%) in 1- to 9-year-old. The average level of anti-HBc maintains 5.99% in children aged 1- to 16-year with 0.63% for HBsAg. CONCLUSION: This is the first study of the prevalence of anti-HBc in vaccinated Chinese children: 36.6% of anti-HBc-positivity was found in 0-year-old group, which could be maternal in origin. Relatively high prevalence of anti-HBc may not be ignored in children aged 1- to 16-year-old. Strangely, our data also showed that HBV breakthrough infection would occur in immunized Chinese children older than 9-year-old, and more attention is needed on those children.
引用
- Yang YT, Huang AL, Zhao Y, et al. The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study. Vaccine. 2018. PMID: 30527659. doi:10.1016/j.vaccine.2018.11.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。